Global Sickle Cell Anemia Testing & Screening Market
Global Sickle Cell Anemia Testing & Screening Market Forecast 2023-2030: Agios Pharmaceuticals, Bio-Rad, and Quest Diagnostics Among Key Players in Market
August 21, 2023 05:43 ET | Research and Markets
Dublin, Aug. 21, 2023 (GLOBE NEWSWIRE) -- The "Global Sickle Cell Anemia Testing & Screening Market by Technology, Age Group, Sector - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and...
NMDP-BTM_Dual_2_Color_BlueGreen_Logo_RGB_2000x542 (1).png
Cheek Week Kicks Off July 10 in Support of African American Bone Marrow Awareness Month
July 10, 2023 10:33 ET | Be The Match
ATLANTA, July 10, 2023 (GLOBE NEWSWIRE) -- Did you know that a simple cheek swab can help cure blood cancer like leukemia or blood disorders such as sickle cell disease? Cheek Week, now in its...
The Gazelle Hb Variant Test
Hemex Health Awarded $3M NIH Grant to Bring Gazelle Hb Variant Test for Sickle Cell Disease to US Market
March 27, 2023 08:00 ET | Hemex Health
PORTLAND, Ore., March 27, 2023 (GLOBE NEWSWIRE) -- Hemex Health, a medical diagnostic device company focused on expanding healthcare access to underrepresented patient populations, announced it has...
Sickle Cell Disease Treatment Market Size to Surpass Around USD 8.75 Billion by 2029 | Research Report by Fortune Business Insights
January 09, 2023 05:18 ET | Fortune Business Insights
Pune, India, Jan. 09, 2023 (GLOBE NEWSWIRE) -- The global sickle cell disease treatment market size was valued at USD 1.73 billion in 2021. The market is projected to grow from USD 2.25 billion in...
LOGO roboto color with gray.png
Folia Health Technology Platform Used in First-of-its-Kind Real World Evidence Study for Sickle Cell Disease
September 15, 2022 15:23 ET | Folia Health
BOSTON, Sept. 15, 2022 (GLOBE NEWSWIRE) -- Today, Folia Health announced the initiation of the ASCEND Study, a first-of-its-kind, at-home observational real-world evidence study in which people...
AMR Logo.png
Global Hemoglobinopathies Market is Expected to Reach $7.0 Billion by 2031: Says AMR
August 25, 2022 08:33 ET | Allied Market Research
Portland, OR, Aug. 25, 2022 (GLOBE NEWSWIRE) -- The Global Hemoglobinopathies Market size was estimated at $4.2 billion in 2021 and is expected to hit $7.0 billion by 2031, registering a CAGR of...
Straits Research Pvt Ltd
CRISPR Gene Editing Market Size is projected to reach USD 14.80 Billion by 2030, growing at a CAGR of 29.80%: Straits Research
August 01, 2022 12:40 ET | Straits Research
New York, United States, Aug. 01, 2022 (GLOBE NEWSWIRE) -- CRISPR Gene Editing, also called genome editing, modifies an organism's DNA. This method replaces, adds, or removes genetic material from...
Global Blood and Plasma Components Market
Global Blood and Plasma Components Market Report 2022: A $66.47 Billion Market in 2031 - Increase in Adoption of Business Expansion Strategies in the Market
June 10, 2022 04:48 ET | Research and Markets
Dublin, June 10, 2022 (GLOBE NEWSWIRE) -- The "Blood and Plasma Components Market - A Global and Regional Analysis: Focus on Product, Application, End User and Region - Analysis and Forecast,...
Inserting the Hb variant cartridge into the Gazelle Reader for analysis
Hemex Health announces breakthrough measurement capability for clinicians monitoring sickle cell disease therapy
May 08, 2022 06:00 ET | Hemex Health
PORTLAND, Ore. and MUMBAI, India, May 08, 2022 (GLOBE NEWSWIRE) -- Hemex Health, a Portland, Oregon-based health-tech startup, announced a significant enhancement to their Gazelle™ Hb Variant test,...
Imara-Logo-Color-RGB.jpg
Imara Announces FDA Clearance of Investigational New Drug Application (IND) for Tovinontrine (IMR-687) for Heart Failure with Preserved Ejection Fraction (HFpEF)
January 25, 2022 07:00 ET | Imara, Inc.
Expanding patient base and potential of Imara’s small molecule oral inhibitor of phosphodiesterase-9 (PDE9) alongside hemoglobin disorders Phase 2 trial aims to select HFpEF patients with enriched...